BACKGROUND & AIMS: Ghrelin is the only peripheral hormone known to increase food intake. It is released from the stomach and is thought to function as a signal of energy deficit and a meal initiator. We generated transgenic mice in which levels of bioactive ghrelin are increased in the stomach and circulation. These mice, as expected, are hyperphagic and glucose intolerant. We investigated whether exposure to a high-fat diet (HFD) would exacerbate this phenotype. METHODS: We investigated the effect of HFD on energy and glucose homeostasis in ghrelin transgenic mice. We determined dietary preference; expression of hypothalamic neuropeptides that control food intake; and, using fast-performance liquid chromatography, the circulating forms of ghrelin. We measured food intake during continuous administration of ghrelin in wild-type mice fed either regular chow or an HFD. RESULTS: Ghrelin transgenic mice were resistant to diet-induced obesity because of their reduced food intake. This was not caused by alterations to food preference, hypothalamic signaling of neuropeptides that control food intake, or the form of circulating acylated ghrelin. Long-term administration of ghrelin to wild-type mice failed to increase ingestion of an HFD but, as expected, increased intake of regular chow. CONCLUSIONS: This is the first report that diets high in fat inhibit the hyperphagic effect of ghrelin; these findings indicate that features of the diet are important determinants of ghrelin's function. This information is important for the development of anti-obesity drugs that target ghrelin signaling. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
BACKGROUND & AIMS:Ghrelin is the only peripheral hormone known to increase food intake. It is released from the stomach and is thought to function as a signal of energy deficit and a meal initiator. We generated transgenic mice in which levels of bioactive ghrelin are increased in the stomach and circulation. These mice, as expected, are hyperphagic and glucose intolerant. We investigated whether exposure to a high-fat diet (HFD) would exacerbate this phenotype. METHODS: We investigated the effect of HFD on energy and glucose homeostasis in ghrelintransgenic mice. We determined dietary preference; expression of hypothalamic neuropeptides that control food intake; and, using fast-performance liquid chromatography, the circulating forms of ghrelin. We measured food intake during continuous administration of ghrelin in wild-type mice fed either regular chow or an HFD. RESULTS:Ghrelintransgenic mice were resistant to diet-induced obesity because of their reduced food intake. This was not caused by alterations to food preference, hypothalamic signaling of neuropeptides that control food intake, or the form of circulating acylated ghrelin. Long-term administration of ghrelin to wild-type mice failed to increase ingestion of an HFD but, as expected, increased intake of regular chow. CONCLUSIONS: This is the first report that diets high in fat inhibit the hyperphagic effect of ghrelin; these findings indicate that features of the diet are important determinants of ghrelin's function. This information is important for the development of anti-obesity drugs that target ghrelin signaling. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Authors: Stephen Kentish; Hui Li; Lisa K Philp; Tracey A O'Donnell; Nicole J Isaacs; Richard L Young; Gary A Wittert; L Ashley Blackshaw; Amanda J Page Journal: J Physiol Date: 2011-11-07 Impact factor: 5.182
Authors: Diego Perez-Tilve; Kristy Heppner; Henriette Kirchner; Sarah H Lockie; Stephen C Woods; David L Smiley; Matthias Tschöp; Paul Pfluger Journal: FASEB J Date: 2011-05-04 Impact factor: 5.191
Authors: Ali Yasrebi; Anna Hsieh; Kyle J Mamounis; Elizabeth A Krumm; Jennifer A Yang; Jason Magby; Pu Hu; Troy A Roepke Journal: Mol Cell Endocrinol Date: 2015-11-11 Impact factor: 4.102
Authors: Bharath K Mani; Nancy Puzziferri; Zhenyan He; Juan A Rodriguez; Sherri Osborne-Lawrence; Nathan P Metzger; Navpreet Chhina; Bruce Gaylinn; Michael O Thorner; E Louise Thomas; Jimmy D Bell; Kevin W Williams; Anthony P Goldstone; Jeffrey M Zigman Journal: J Clin Invest Date: 2019-09-03 Impact factor: 14.808